Open AccessTime to abandon placebo control in pivotal phase III trials?
Author(s) -
Geddes John R.,
Cipriani Andrea
Publication year - 2015
Publication title -
world psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 15.51
H-Index - 93
eISSN - 2051-5545
pISSN - 1723-8617
DOI - 10.1002/wps.20246
Subject(s) - medicine , antidepressant , placebo , clinical trial , psychiatry , depression (economics) , population , drug development , randomized controlled trial , intensive care medicine , alternative medicine , drug , anxiety , pathology , environmental health , economics , macroeconomics